X
Biofrontera mulls US IPO to fund skin cancer drug
https://pharmaphorum.com/news/biofrontera-considers-us-listing-fund-skin-cancer-drug/
IPO
Biotech IPO market heats up as BioHaven’s debut impresses
May 5, 2017BioHaven raises $168 million with biggest biotech IPO seen this year.
Are biotech IPOs back in fashion?
April 19, 2017
Tocagen aims for IPO to fund brain cancer trial
March 13, 2017
Jounce set to make first biotech IPO of 2017
January 4, 2017Massachusetts-based company will test the waters for biotech sector
CRISPR Therapeutics plans Nasdaq launch
September 12, 2016
Never mind the chill, biotech IPO winter will pass
April 27, 2016
